A 2018 review of 16 reports of cannabis-based medicines for neuropathic ache, the vast majority of which analyzed a cannabinoid preparing referred to as nabiximols (brand name Sativex; a mouth spray containing both of those THC and CBD that may be authorized in a few nations around the world but not in the United States), identified very low- to mo